Impact of Solitary Involved Lymph Node on Outcome in Localized Cancer of the Esophagus and Esophagogastric Junction

被引:0
|
作者
James M. O’Riordan
Suzanne Rowley
James O. Murphy
Narayasami Ravi
Patrick J. Byrne
John V. Reynolds
机构
[1] St James’ Hospital and Trinity College,University Department of Surgery, Trinity College Centre for Health Sciences
来源
Journal of Gastrointestinal Surgery | 2007年 / 11卷
关键词
Lymph node; Esophagectomy; Lymphadenectomy; Survival;
D O I
暂无
中图分类号
学科分类号
摘要
Node-positive esophageal cancer is associated with a dismal prognosis. The impact of a solitary involved node, however, is unclear, and this study examined the implications of a solitary node compared with greater nodal involvement and node-negative disease. The clinical and pathologic details of 604 patients were entered prospectively into a database from1993 and 2005. Four pathologic groups were analyzed: node-negative, one lymph node positive, two or three lymph nodes positive, and greater than three lymph nodes positive. Three hundred and fifteen patients (52%) were node-positive and 289 were node-negative. The median survival was 26 months in the node-negative group. Patients (n = 84) who had one node positive had a median survival of 16 months (p = 0.03 vs node-negative). Eighty-four patients who had two or three nodes positive had a median survival of 11 months compared with a median survival of 8 months in the 146 patients who had greater than three nodes positive (p = 0.01). The survival of patients with one node positive [number of nodes (N) = 1] was also significantly greater than the survival of patients with 2–3 nodes positive (N = 2–3) (p = 0.049) and greater than three nodes positive (p < 0001). The presence of a solitary involved lymph node has a negative impact on survival compared with node-negative disease, but it is associated with significantly improved overall survival compared with all other nodal groups.
引用
收藏
页码:493 / 499
页数:6
相关论文
共 50 条
  • [41] Sentinel-Lymph Node-Mapping in Adenocarcinoma of the esophagogastric Junction
    Goetzky, K.
    Jaehne, J.
    CHIRURG, 2014, 85 (12): : 1111 - 1111
  • [42] Frequency and clinical impact of lymph node micrometastasis and tumor cell microinvolvement in patients with adenocarcinoma of the esophagogastric junction
    Mueller, JD
    Stein, HJ
    Oyang, T
    Natsugoe, S
    Feith, M
    Werner, M
    Siewert, JR
    CANCER, 2000, 89 (09) : 1874 - 1882
  • [43] Esophagogastric junction cancer and classification as esophagus cancer according to molecular fingerprint
    Barra, Williams Fernandes
    Khayat, Andre Salim
    Moreirat, Fabiano C.
    Demachki, Sarnia
    Santos, Andrea K. C. R.
    Santos, Sidney E. B.
    Assumpcao, Paulo P.
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [44] Rate of Lymph Node Metastasis and Outcome of Endoscopic Resection for High Grade Dysplasia and Superficial Adenocarcinoma of the Esophagogastric Junction
    Yamada, Masayoshi
    Oda, Ichiro
    Nonaka, Satoru
    Suzuki, Haruhisa
    Yoshinaga, Shigetaka
    Saito, Yutaka
    Taniguchi, Hirokazu
    Sekine, Shigeki
    Kushima, Ryoji
    GASTROINTESTINAL ENDOSCOPY, 2012, 75 (04) : 234 - 234
  • [45] Cancer of the Esophagus and Esophagogastric Junction: An Eighth Edition Staging Primer
    Rice, Thomas W.
    Ishwaran, Hemant
    Ferguson, Mark K.
    Blackstone, Eugene H.
    Goldstraw, Peter
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : 36 - 42
  • [46] THE IMPACT OF LYMPH NODE DENSITY ON OUTCOME IN LYMPH NODE-POSITIVE CERVICAL CANCER PATIENTS
    Yoon, A.
    Lee, Y. Y.
    Kim, T. H.
    Choi, J. K.
    Yoon, G. U. N.
    Kim, T. J.
    Lee, J. W.
    Kim, B. G.
    Bae, D. S.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2014, 24 (09) : 562 - 562
  • [47] Involved-field chemoradiotherapy for postoperative solitary lymph node recurrence of esophageal cancer
    Kawamoto, Terufumi
    Nihei, Keiji
    Sasai, Keisuke
    Karasawa, Katsuyuki
    ESOPHAGUS, 2018, 15 (04) : 256 - 262
  • [48] Involved-field chemoradiotherapy for postoperative solitary lymph node recurrence of esophageal cancer
    Terufumi Kawamoto
    Keiji Nihei
    Keisuke Sasai
    Katsuyuki Karasawa
    Esophagus, 2018, 15 : 256 - 262
  • [50] Should the splenic hilar lymph node be dissected for the management of adenocarcinoma of the esophagogastric junction?
    Kumazu, Yuta
    Hasegawa, Shinichi
    Hayashi, Tsutomu
    Yamada, Takanobu
    Watanabe, Hayato
    Hara, Kentaro
    Shimoda, Yota
    Nakazono, Masato
    Nagasawa, Shinsuke
    Rino, Yasushi
    Masuda, Munetaka
    Ogata, Takashi
    Oshima, Takashi
    Yoshikawa, Takaki
    EJSO, 2023, 49 (01): : 76 - 82